{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:56:36Z","timestamp":1783547796683,"version":"3.55.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004515","name":"Universiti Kebangsaan Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2020\/SKK0\/UKM\/01\/4"],"award-info":[{"award-number":["FRGS\/1\/2020\/SKK0\/UKM\/01\/4"]}],"id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked hereditary disorder and a global public health concern that is most prevalent in malaria-endemic regions including Asia, Africa, and the Mediterranean. G6PD-deficient individuals are at high risk of developing acute hemolytic anemia following treatment with antimalarial drugs including Primaquine and Tafenoquine. However, the currently available tests for G6PD screening are complex and often have been misclassifying cases, particularly for females with intermediate G6PD activity. The latest innovation of quantitative point-of-care (POC) tests for G6PD deficiency provides an opportunity to improve population screening and prevent hemolytic disorders when treating malaria. Aim(s): To assess the evidence on the type and performance of quantitative point-of-care (POC) tests for effective G6PD screening and hence, radical elimination of <jats:italic>Plasmodium<\/jats:italic> malaria infections.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Relevant studies published in English language confined from two databases, Scopus and ScienceDirect were searched from November 2016 onwards. The search was conducted using keywords including \u201cglucosephosphate dehydrogenase\u201d or \u201cG6PD\u201d, \u201cpoint-of-care\u201d, \u201cscreening\u201d or \u201cprevalence\u201d, \u201cbiosensor\u201d and \u201cquantitative\u201d. The review was reported following the PRISMA guidelines.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Initial search results yielded 120 publications. After thorough screening and examination, a total of 7 studies met the inclusion criteria, and data were extracted in this review. Two types of quantitative POC tests were evaluated, namely, the CareStart<jats:sup>TM<\/jats:sup> Biosensor kit and the STANDARD G6PD kit. Both tests showed promising performance with high sensitivity and specificity ranging mostly from 72% to 100% and 92%\u2013100%, respectively. The positive and negative predictive values (PPV and NPV) ranged from 35% to 72% and 89%\u2013100%, with accuracy ranging from 86% to 98%.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> In areas with a high prevalence of G6PD deficiency that overlap with malaria endemicity, availability and validation of the diagnostic performance of quantitative POC tests are of absolute importance. Carestart\u2122 biosensor and STANDARD G6PD kits showed high reliability and performed well in comparison to the spectrophotometric reference standard.<\/jats:p>","DOI":"10.3389\/fgene.2023.1098828","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T05:35:01Z","timestamp":1686720901000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Population screening for glucose-6-phosphate dehydrogenase deficiency using quantitative point-of-care tests: a systematic review"],"prefix":"10.3389","volume":"14","author":[{"given":"Mohamed Afiq Hidayat","family":"Zailani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja Zahratul Azma","family":"Raja Sabudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azlin","family":"Ithnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiza","family":"Alauddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Aishah","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endom","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainoon","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/humu.9103","article-title":"Glucose-6-phosphate dehydrogenase (G6PD) variants in Malaysian Malays","volume":"21","author":"Ainoon","year":"2003","journal-title":"Hum. Mutat."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0206331","DOI":"10.1371\/journal.pone.0206331","article-title":"Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity","volume":"13","author":"Alam","year":"2018","journal-title":"PLoS ONE"},{"key":"B3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/sj.bmt.1705796","article-title":"G6PD deficiency from lyonization after hematopoietic stem cell transplantation from female heterozygous donors","volume":"40","author":"Au","year":"2007","journal-title":"Bone marrow Transplant."},{"key":"B4","doi-asserted-by":"publisher","first-page":"tay100","DOI":"10.1093\/jtm\/tay110","article-title":"Tafenoquine for travelers\u2019 malaria: Evidence, rationale and recommendations","volume":"25","author":"Baird","year":"2018","journal-title":"J. Travel Med."},{"key":"B5","doi-asserted-by":"crossref","first-page":"e0196716","DOI":"10.1371\/journal.pone.0196716","article-title":"Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood","volume":"13","author":"Bancone","year":"2018","journal-title":"PLoS ONE"},{"key":"B6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1182\/blood.V32.5.816.816","article-title":"Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency","volume":"32","author":"Beutler","year":"1968","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12936-018-2248-y","article-title":"Primaquine-induced haemolysis in females heterozygous for G6PD deficiency","volume":"17","author":"Chu","year":"2018","journal-title":"Malar. J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.12688\/wellcomeopenres.15100.2","article-title":"The impact of using primaquine without prior G6PD testing: A case series describing the obstacles to the medical management of haemolysis","volume":"4","author":"Chu","year":"2019","journal-title":"Wellcome Open Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5694\/mja2.50474","article-title":"Tafenoquine for the radical cure and prevention of malaria: The importance of testing for G6PD deficiency","volume":"212","author":"Commons","year":"2020","journal-title":"Med. J. Aust."},{"key":"B10","article-title":"Tafenoquine therapy and G6PD genotype. 2020 oct 13","volume-title":"Medical genetics summaries [internet]","author":"Dean","year":"2012"},{"key":"B11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40249-021-00889-2","article-title":"Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania","volume":"10","author":"Djigo","year":"2021","journal-title":"Infect. Dis. Poverty"},{"key":"B12","doi-asserted-by":"crossref","first-page":"e011458","DOI":"10.1136\/bmjopen-2016-011458","article-title":"Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)","volume":"6","author":"Downes","year":"2016","journal-title":"BMJ Open"},{"key":"B13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12936-021-03743-w","article-title":"Implementing radical cure diagnostics for malaria: User perspectives on G6PD testing in Bangladesh","volume":"20","author":"Engel","year":"2021","journal-title":"Malar. J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"17106","DOI":"10.1038\/s41598-020-74200-y","article-title":"Glucose-6-phosphate dehydrogenase deficiency in the han Chinese population: Molecular characterization and genotype-phenotype association throughout an activity distribution","volume":"10","author":"He","year":"2020","journal-title":"Sci. Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12936-018-2390-6","article-title":"Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia","volume":"17","author":"Henriques","year":"2018","journal-title":"Malar. J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"105904","DOI":"10.1016\/j.phrs.2021.105904","article-title":"The ethnogeographic variability of genetic factors underlying G6PD deficiency","volume":"173","author":"Koromina","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"875877","DOI":"10.3389\/fped.2022.875877","article-title":"Glucose-6-Phosphate dehydrogenase deficiency and neonatal hyperbilirubinemia: Insights on pathophysiology, diagnosis, and gene variants in disease heterogeneity","volume":"10","author":"Lee","year":"2022","journal-title":"Front. Pediatr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12936-015-0896-8","article-title":"The challenges of introducing routine G6PD testing into radical cure: A workshop report","volume":"14","author":"Ley","year":"2015","journal-title":"Malar. J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0169930","DOI":"10.1371\/journal.pone.0169930","article-title":"A comparison of three quantitative methods to estimate G6PD activity in the Chittagong Hill Tracts, Bangladesh","volume":"12","author":"Ley","year":"2017","journal-title":"PLoS ONE"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood.2019000944","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"136","author":"Luzzatto","year":"2020","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12936-020-03359-6","article-title":"G6PD deficiency in malaria endemic areas of Nepal","volume":"19","author":"Marasini","year":"2020","journal-title":"Malar. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"n7.1","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4269\/ajtmh.18-0612","article-title":"Evaluation of a novel quantitative test for glucose-6-phosphate dehydrogenase deficiency: Bringing quantitative testing for glucose-6-phosphate dehydrogenase deficiency closer to the patient","volume":"100","author":"Pal","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0226927","DOI":"10.1371\/journal.pone.0226927","article-title":"Evaluation of quantitative biosensor for glucose-6-phosphate dehydrogenase activity detection","volume":"14","author":"Pengboon","year":"2019","journal-title":"PLoS ONE"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1003084","DOI":"10.1371\/journal.pmed.1003084","article-title":"Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis","volume":"17","author":"Pfeffer","year":"2020","journal-title":"PLOS Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1136\/bmjebm-2020-111474","article-title":"Delays in publishing systematic review registrations in PROSPERO are hindering transparency and may lead to research waste","volume":"26","author":"Puljak","year":"2021","journal-title":"BMJ Evidence-Based Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bjh.16366","article-title":"Laboratory diagnosis of G6PD deficiency: A British society for haematology guideline","volume":"189","author":"Roper","year":"2020","journal-title":"Br. J. Haematol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jclinepi.2019.08.010","article-title":"Half of systematic reviews about pain registered in PROSPERO were not published and the majority had inaccurate status","volume":"116","author":"Runjic","year":"2019","journal-title":"J. Clin. Epidemiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/bmjebm-2020-111361","article-title":"Does the PROSPERO registration prevent double review on the same topic?","volume":"26","author":"Solla","year":"2021","journal-title":"BMJ Evid. Based Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/wellcomeopenres.13373.1","article-title":"Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: A cohort study","volume":"3","author":"Thielemans","year":"2018","journal-title":"Wellcome Open Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.4269\/ajtmh.16-0714","article-title":"Field trial of the carestart biosensor analyzer for the determination of glucose-6-phosphate dehydrogenase activity in Haiti","volume":"97","author":"Weppelmann","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B32","article-title":"Point-of-care G6PD testing to support safe use of primaquine for the treatment of vivax malaria","volume-title":"WHO evidence review group meeting report","year":"2014"},{"key":"B33","volume-title":"Point-of-care G6PD testing to support safe use of primaquine for the treatment of vivax malaria","year":"2015"},{"key":"B34","volume-title":"Technical specifications series for submission to WHO prequalification\u2014diagnostic assessment:","year":"2016"},{"key":"B35","volume-title":"Revision of WHO classification of G6PD variants and international classification of diseases (ICD)-11","year":"2019"},{"key":"B36","volume-title":"Malaria policy advisory group meetingTechnical consultation to review the classification of glucose-6-phosphate dehydrogenase (G6PD)","year":"2022"},{"key":"B37","volume-title":"Malaria","year":"2023"},{"key":"B38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3389\/fped.2022.875877","article-title":"Evaluation of the diagnostic accuracy of the CareStart\u2122 glucose-6-phosphate dehydrogenase deficiency rapid diagnostic test among Chinese newborns","volume":"66","author":"Yu","year":"2020","journal-title":"J. Trop. Pediatr."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1010172","DOI":"10.3389\/fpubh.2022.1010172","article-title":"Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of Hainan Province, China","volume":"10","author":"Zeng","year":"2022","journal-title":"Front. Public Health"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0009649","DOI":"10.1371\/journal.pntd.0009649","article-title":"Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil","volume":"15","author":"Zobrist","year":"2021","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1098828\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T05:35:13Z","timestamp":1686720913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1098828\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":40,"alternative-id":["10.3389\/fgene.2023.1098828"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2023.1098828","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"article-number":"1098828"}}